We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

99 hedge funds and large institutions have $467M invested in Cullinan Oncology in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,100% more call options, than puts

Call options by funds: $504K | Put options by funds: $2K

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

36% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 28

11% more funds holding

Funds holding: 89 → 99 (+10)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1% less capital invested

Capital invested by funds: $473M → $467M (-$6.62M)

2.74% less ownership

Funds ownership: 83.91% → 81.18% (-2.7%)

Holders
99
Holders Change
+10
Holders Change %
+11.24%
% of All Funds
1.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
38
Reduced
28
Closed
8
Calls
$504K
Puts
$2K
Net Calls
+$502K
Net Calls Change
+$152K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$8.15M
2
RCMNY
Rubric Capital Management (New York)
New York
+$3.54M
3
CA
CHI Advisors
New York
+$2.63M
4
Goldman Sachs
Goldman Sachs
New York
+$2.18M
5
BlackRock
BlackRock
New York
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$14.9M
2
WP
Woodline Partners
California
-$10.5M
3
Millennium Management
Millennium Management
New York
-$2.32M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.8M
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$1.66M -$1.14M -84,532 -39%
AQR Capital Management
27
AQR Capital Management
Connecticut
$1.39M +$1.18M +87,493 +418%
N
28
Nuveen
North Carolina
$1.38M +$18.1K +1,347 +1%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.36M +$183K +13,574 +15%
Norges Bank
30
Norges Bank
Norway
$1.31M +$1.37M +101,900 New
UBS Group
31
UBS Group
Switzerland
$1.17M -$9.55K -709 -0.8%
AI
32
Atom Investors
Texas
$1.04M -$216K -16,009 -17%
HS
33
HighVista Strategies
Massachusetts
$1.02M +$1.08M +79,918 New
American Century Companies
34
American Century Companies
Missouri
$1.01M +$1.06M +79,024 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$993K -$236K -17,546 -18%
Bank of America
36
Bank of America
North Carolina
$806K +$461K +34,227 +119%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$587K +$35.8K +2,659 +6%
Victory Capital Management
38
Victory Capital Management
Texas
$538K +$566K +41,980 New
VRS
39
Virginia Retirement Systems
Virginia
$537K +$565K +41,900 New
Marshall Wace
40
Marshall Wace
United Kingdom
$520K -$34.3K -2,547 -6%
MAM
41
Martingale Asset Management
Massachusetts
$398K +$418K +31,016 New
Swiss National Bank
42
Swiss National Bank
Switzerland
$396K – – –
Acadian Asset Management
43
Acadian Asset Management
Massachusetts
$344K +$362K +26,901 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$342K +$32.3K +2,400 +10%
Wellington Management Group
45
Wellington Management Group
Massachusetts
$337K -$6.26K -465 -2%
BC
46
Birchview Capital
Vermont
$322K -$269K -20,000 -44%
AA
47
ALPS Advisors
Colorado
$320K -$21.9K -1,624 -6%
TI
48
Trexquant Investment
Connecticut
$303K -$110K -8,194 -26%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$302K -$1.08K -80 -0.3%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$296K +$73.8K +5,479 +31%
1
2
3 4 5

CGEM Hedge Fund Activity: Q3 2022 in Review

99 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q3 2022, worth a combined $467M — down 1.4% from $473M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CGEM positions and 8 closed out — a net gain of 10 holders — while 38 added to existing stakes and 28 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $8.15M. The largest seller was Baupost Group, cutting an estimated $14.9M.

  • 99 institutional investors held Cullinan Oncology (CGEM) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $467M of Cullinan Oncology stock for Q3 2022, down 1.4% quarter-over-quarter.
  • 18 funds opened new Cullinan Oncology positions in Q3 2022 and 8 closed out, a net change of +10 holders.
  • The largest Cullinan Oncology buyer in Q3 2022 was Kennedy Capital Management, an estimated $8.15M added.
  • The largest Cullinan Oncology seller in Q3 2022 was Baupost Group, an estimated $14.9M sold.

Based on aggregated 13F filings for Q3 2022.